Clinical Trial Update: Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx [NA]

View source ↗

Summary

A Duke University-sponsored trial is testing radiotherapy dose de-escalation for HPV-associated oropharyngeal cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Snippet

Sponsor: Duke University | Conditions: Oropharynx Cancer | NA | Status: RECRUITING